Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 2-1Hematology Research
  • Track 2-2Blood Components
  • Track 2-3Erythrocytes and Leukocytes
  • Track 2-4Platelets and Thrombocytopenia
  • Track 2-5Hemoglobin and Blood Plasma
  • Track 2-6Complete Blood Count and Polycythemia
  • Track 2-7Different Types of Anemia
  • Track 2-8Polymorphism and Hematopoiesis
  • Track 4-1Acute and Chronic Lymphoblastic Leukemia
  • Track 4-2Hodgkins and Non-Hodgkins Lymphoma
  • Track 4-3Myelodysplastic Syndromes
  • Track 4-4Multiple Myeloma
  • Track 4-5Myeloma Cancer
  • Track 4-6Myeloid Leukemia
  • Track 4-7
  • Track 8-1Molecular Pathogenesis
  • Track 8-2Genetic Blood Disorders
  • Track 8-3Hemophilia A, B and C
  • Track 8-4Idiopathic Thrombocytopenic Purpura (ITP)
  • Track 8-5Von Willebrand
  • Track 8-6Bleeding Disorders
  • Track 8-7Coagulation Factors
  • Track 8-8Hemoglobinopathies
  • Track 8-9Biomarkers for Blood Cancers
  • Track 9-1Diagnostics
  • Track 9-2Splenectomy
  • Track 10-1Umbilical Cord Blood Transplantation
  • Track 10-2Bone Marrow Transplantation
  • Track 10-3Autologous Transplantation
  • Track 10-4Thromboembolism
  • Track 10-5Hemostasis
  • Track 10-6Metabolic Syndrome
  • Track 11-1Biological Drugs
  • Track 11-2Generic Drugs
  • Track 11-3Increasing Investments
  • Track 11-4Healthcare Expenditures
  • Track 11-5Cancer Pharmaceutical Companies
  • Track 12-1B and T-Lymphocyte
  • Track 12-2Clinical Immunology
  • Track 12-3Immunology of Blood Cancer
  • Track 12-4Autoimmune Diseases
  • Track 12-5Stem Cell Transplantation Strategies
  • Track 13-1Gene therapy
  • Track 13-2Vena Cava Filters
  • Track 13-3Surgery, Chemotherapy and Radiotherapy
  • Track 13-4Targeted therapy
  • Track 13-5Role of Translational Medicine